Hereditary Spastic Paraparesis: Clinical Trials

7 trials for Hereditary Spastic Paraparesis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 active not recruiting, 1 not yet recruiting. 4 Not applicable, 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable4Recruiting 2, Active not recruiting 1, Completed 1
Phase 22Completed 1, Not yet recruiting 1
Phase 11Not yet recruiting 1

Follow Hereditary Spastic Paraparesis: new trials by email Literature Review of Hereditary Spastic Paraparesis trials Research Report on Hereditary Spastic Paraparesis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47)
BFB-101 (AAV9-CBh-AP4B1) - HSP, Hereditary Spastic Paraplegia
Phase 1 / Phase 2Not yet recruitingBlackfinBio Ltd52025-08-012025-04-28
Enhancement of Quality of Work And Life
Preventive Participatory workplace intervention - Parkinson Disease, Hereditary Spastic Paraparesis
Not applicableActive not recruitingRadboud University Medical Center1242024-10-082026-08-14
Evaluation of an Intensive Training Program for Patients with Hereditary Spastic Paraparesis SPG4/Spast
intensive reeducation - Hereditary Spastic Paraparesis
Not applicableRecruitingAssistance Publique - Hôpitaux de Paris502024-04-042024-11-25
The Effect of Targeting the Plantaris Muscle-tendon in Surgical Correction of Ankle Equinus in Children
Tendoachilles (TA) lengthening or gastrocnemius (GN) recession, then Plantaris tenotomy, Plantaris tenotomy, then Tendoachilles (TA) lengthening or gastrocnemius (GN) recession - Idiopathic Toe Walking, Cerebral Palsy
Not applicableRecruitingUniversity of Alberta422023-03-132026-03-12
Testing Miglustat Administration in Subjects With Spastic Paraplegia 11
Miglustat 100 MG - Hereditary Spastic Paraparesis
Phase 2CompletedIRCCS Fondazione Stella Maris102021-06-152022-04-11
SNAP: Measurement of the Subjective Perception of the Symptom in Hereditary Spastic Paraparesis (HSP)
SNAP questionnaire - Hereditary Spastic Paraparesis
Not applicableCompletedIRCCS Eugenio Medea802018-10-302021-11-26
Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
No intervention - Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease
CompletedMassachusetts General Hospital4752008-04-012016-06-03

Narrower conditions

Spastic Paraplegia, Hereditary (7)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Brain Injuries, Traumatic (1)  ·  Cerebellar Ataxia (1)  ·  Cerebral Palsy (1)  ·  Charcot-Marie-Tooth Disease (1)  ·  Mitochondrial Diseases (1)  ·  Motor Neuron Disease (1)  ·  Movement Disorders (1)  ·  Muscle Spasticity (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Parkinson Disease (1)  ·  Spinal Cord Injuries (1)

Broader conditions

Congenital Abnormalities (7)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7)  ·  Genetic Diseases, Inborn (7)  ·  Hereditary Sensory and Motor Neuropathy (7)  ·  Heredodegenerative Disorders, Nervous System (7)  ·  Nervous System Malformations (7)  ·  Peripheral Nervous System Diseases (7)  ·  Polyneuropathies (7)  ·  Nervous System Diseases (6)  ·  Neurodegenerative Diseases (6)  ·  Neuromuscular Diseases (6)  ·  Central Nervous System Diseases (4)  ·  Brain Diseases (2)  ·  Metabolic Diseases (2)  ·  Neurologic Manifestations (2)

Interventions

miglustat (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  BlackfinBio Ltd (1)  ·  IRCCS Eugenio Medea (1)  ·  IRCCS Fondazione Stella Maris (1)  ·  Massachusetts General Hospital (1)  ·  Radboud University Medical Center (1)  ·  University of Alberta (1)

Countries

Canada (2)  ·  Italy (2)  ·  United States (2)  ·  France (1)  ·  Netherlands (1)

Top investigators

Elbrich Postma, PhD (1)  ·  Filippo M Santorelli, MD PhD (1)  ·  James D. Berry, MD, MPH (1)  ·  Sukhdeep Dulai, MD, MHSc, FRCSC (1)

Results publications

PMID 38557877, PMID 41491634

NIH funding

2019 (1), 5RC1NS068179-02 (1)